Adding a drug that targets a molecular vulnerability in pancreatic cancer could provide substantial benefit to patients, according to a clinical trial study by the HonorHealth Research Institute and the Translational Genomics ...
Oct 3, 2019
A national rule meant to increase the number of heart transplants for the sickest children has not resulted in improved survival, a new study has found.
Oct 3, 2019
Over half of people prescribed the targeted blood cancer-fighting drug ibrutinib developed new or worsened high blood pressure within six months of starting the medication, according to a new study published online today ...
Oct 3, 2019
